Scalable and cost-effective generation of osteogenic micro-tissues through incorporation of inorganic microparticles within mesenchymal stem cell spheroids.
Mesenchymal stem cells (MSCs) are considered primary candidates for treating complex bone defects in cell-based therapy and tissue engineering. Compared with monolayer cultures, spheroid cultures of MSCs (mesenspheres) are favorable due to their increased potential for differentiation, extracellular matrix (ECM) synthesis, paracrine activity, and in vivo engraftment. Here, we present a microparticle incorporation strategy for fabrication of osteognic microtissues from mesenspheres in a cost-effective and scalable manner. A facile method was developed to synthesize mineral microparticles with cell-sized spherical shape, biphasic calcium posphate composition (hydroxyaptite and β-tricalcium phosphate), and a microporous structure. The calcium phosphate microparticles (CMPs) were icorporated within the mesenspheres through mixing with the single cells during cell aggregation. Interestingly, the osteogenic genes were upregulated significantly (Col I; 30-fold, OPN; 10-fold, OCN; 3-fold) after the 14-day culture with the incorporated CMPs, while no significant upregulation was observed with incorporation of gelatin microparticles. The porous structure of CMPs was exploited for loading and sustained release of an angiogenic small molecule. Dimethyloxaloylglycine (DMOG) was loaded efficiently onto CMPs (loading efficiency: 65.32±6 %) and showed a sustained release profile over 12 days. Upon incorporation of the DMOG-loaded CMPs (DCMPs) within the mesenspheres, a similar osteogenic differentiation and an upregulation in angiogenic gense (VEGF; 5-fold, KDR; 2-fold) were obsereved after the 14-day culture. These trends were also observed in immunostaining analysis. To evaluate scalable production of the osteogenic micro-tissues, the MP incorporation was performed during cell aggregation in a spinner fask. The DCMPs were efficiently incorporated and directed the mesenspheres toward osteogenesis and angiogenesis. Finally, the DCMP-mesenspheres were loaded within a three-dimensional (3D) printed cell trapper and transplanted into a critical-sized defect in a rat model. Computed tomography and histological analysis showed significant bone formation with blood vessel reconstruction after 8 weeks in this group. Taken together, we provide a scalable and cost-effective approach for fabrication of osteogenic micro-tissues, as building blocks of a macro-tissue, that can address the large amounts of cells required for cell-based therapies.